Shanghai Shyndec Pharmaceutical Co., Ltd. Stock: price and insider trades · China
国药现代
No insider purchase over the last 90 days. The latest, by 李显林, was filed 12 Apr 2023.
Shanghai Shyndec Pharmaceutical Co., Ltd.: what insiders have been doing
Shanghai Shyndec Pharmaceutical Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). No insider at Shanghai Shyndec Pharmaceutical Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 12 April 2023.
The full history, which starts in 2022, counts 3 purchases against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- -33.8%Entry CN¥12.93 · Close at T+365 CN¥8.56
- -2.6%Entry CN¥10.37 · Close at T+365 CN¥10.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 5,200 shares87.0% of flowA股XSHGSSE:173000006475219400Canonical exit: 11 Jul 2023 (T+90)
- 20,000 shares100.0% of flowA股XSHGSSE:173000006147079330Canonical exit: 15 Mar 2023 (T+90)
- 1,000 shares13.0% of flowA股XSHGSSE:173000006147079700Canonical exit: 7 Mar 2023 (T+90)
3 of 3 declarations
About Shanghai Shyndec Pharmaceutical Co., Ltd.
Guoyao Modern is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and distribution of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
